ASTRAZEN Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > astrazen

Technical Analysis

Technical Strength: 6 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 55.4. According to RSI analysis, astrazen is strong. 7.0 ASTRAZEN RSI Chart
MACD (?) MACD: 5.47 and Signal Line: 4.19. According to MACD analysis, astrazen is technically strong. 8.0 ASTRAZEN MACD Chart
Simple Moving Average (?) According to simple moving average analysis, astrazen is in a uptrend. Support level is at 944. 9.0 ASTRAZEN Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, astrazen is facing resistance from it's 200-day exponential moving average at 950.9998 and support level is at 940. 2.0 ASTRAZEN Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.667. 5.0 ASTRAZEN Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 939.6 and 925.5816. Resistance level is 953.6184. 8.0 ASTRAZEN Fibonacci Retracement Chart
Average True Range (?) ATR: 24.2 NA ASTRAZEN Average True Range Chart
Average Directional Index (?) ADX is 20.6 which means ASTRAZEN is in a trading range and there is no trend. NA ASTRAZEN Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 17, 2017
Open Price 951.95
High Price 952.75
Low Price 942.0
Close Price 947.7
Absolute Change -2.2
Percentage Change -0.232%
Weekly Change -0.216%
Monthly Change -2.89%
Yearly Change -1.64%
52-week high 1090.3
52-week low 880.2
Corporate Actions
ExDate Purpose
September 18, 2014 Annual General Meeting
July 09, 2012 AGM/DIV-RS.3.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.469
Confidence in Beta0.233%
Market Capital Rs. 2369.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 2.1
TTM Price-to-Earnings (P/E) Ratio 451
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 17 October 2017: Deliverable Quantity:0 NA ASTRAZEN Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 October 2017: Daily Volatility:0.2102 NA ASTRAZEN Annualized Daily Volatility (Spot Price) Chart


September 15, 2017 AsShareholders meetingstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 13, 2017. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
August 22, 2017 AsShareholders meetingstraZeneca Pharma India Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 13, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 26, 2017 August 08, 2017 inResultsnter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
April 26, 2017 May 09, 2017 iResultsinter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2017. Further that the 'Trading Window' shall remain closed for all Designated Persons, from March 16, 2017 to May 11, 2017 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 931.5 Rs. 936.7 Rs. 942.2 Rs. 947.5 Rs. 953 Rs. 958.2 Rs. 963.7